To report the clinical findings, anatomical features, and treatment outcomes in subjects with ocular tuberculosis (OTB) at 24 months in the Collaborative Ocular Tuberculosis Study (COTS)-1.
Methods:Of the 945 subjects included in the multinational retrospective COTS-1, those who completed 24-month follow-up after completion of treatment were included. Treatment details, anatomical features, and recurrences were noted. The main outcome measure was number of patients with treatment failure (TF).Results: 228 subjects (120 males; mean age of 42.82±14.73 years) were included. The most common phenotype of uveitis was posterior (n=81; 35.53%), and panuveitis (n=76; 33.33%). 52 patients (22.81%) had TF. Subjects with panuveitis (31.58%) and intermediate uveitis (29.63%) accounted for majority of TF. On univariable analysis, odds of high TF was observed with bilaterality (OR:3.46, p=0.003), vitreous haze (OR:2.14, p=0.018), vitreous cells (OR:2.44, p=0.005), and use of immunosuppressive therapies (OR:5.45, p=0.003).Conclusions: Majority of subjects (>75%) achieved cure in the COTS-1 at 24-month follow-up. The concept of "cure" maybe a valuable clinical endpoint in trials assessing treatment of OTB.